TGFB1 and breast cancer: On the basis of the ability of TGF-β in the induction of contractile phenotype during fibroblast-myofibroblast transdifferentiation and on the dual epithelial and contractile phenotype in MECs, this study investigated whether TGF-β can upregulate potential MEC markers that can have functional and clinicopathological significance in breast cancer.